Study finds lack of racial diversity in cancer drug clinical trials
New research published this week in JAMA Oncology has found a lack of racial and ethnic diversity in clinical trials for cancer drugs. The study—conducted by researchers [...]
New research published this week in JAMA Oncology has found a lack of racial and ethnic diversity in clinical trials for cancer drugs. The study—conducted by researchers [...]
A clinical trial testing a new drug in pancreatic cancer had promising initial results, report researchers from the University of Michigan Rogel Cancer Center. A [...]
THURSDAY, Oct. 6, 2016 (HealthDay News) -- Treatment with tamoxifen or another class of drugs called aromatase inhibitors does cut breast cancer patients' risk of developing cancer in their other breast, a new [...]
TUESDAY, Aug. 11, 2015 (HealthDay News) -- Ovarian cancer has a reputation as a swift killer that's often detected at a late stage, but a new study [...]
TUESDAY, Aug. 12 (HealthDay News) — Postmenopausal women with breast cancer who are receiving endocrine treatment may be at increased risk of joint issues, including arthritis, a new study finds. [...]